Your browser doesn't support javascript.
loading
The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.
Xue, Ying; Feng, Zhi-Wei; Li, Xiao-Ye; Hu, Zi-Heng; Xu, Qing; Wang, Zi; Cheng, Jia-Hui; Shi, Hong-Tao; Wang, Qi-Bing; Wu, Hong-Yi; Xie, Xiang-Qun; Lv, Qian-Zhou.
Afiliação
  • Xue Y; Department of Clinical Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Feng ZW; Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; NIH National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, Universi
  • Li XY; Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; NIH National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, Universi
  • Hu ZH; Department of Clinical Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Xu Q; Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; NIH National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, Universi
  • Wang Z; Department of Clinical Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Cheng JH; School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Shi HT; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Wang QB; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Wu HY; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Xie XQ; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Lv QZ; Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy; NIH National Center of Excellence for Computational Drug Abuse Research; Drug Discovery Institute; Departments of Computational Biology and Structural Biology, School of Medicine, Universi
Acta Pharmacol Sin ; 39(2): 205-212, 2018 Feb.
Article em En | MEDLINE | ID: mdl-28933424
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Ticlopidina / Inibidores da Agregação Plaquetária / Aspirina / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Ticlopidina / Inibidores da Agregação Plaquetária / Aspirina / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China